文献速递淋巴瘤

非霍奇金淋巴瘤患者的心理健康:丹麦全国性研究——8750例患者与43750例匹配对照者的精神药物使用情况

Mental health among patients with non-Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators.
PubMed 文献 · Am J Hematol · 2022-03-29

这项前瞻性匹配队列研究利用丹麦全国登记数据,比较8750例非霍奇金淋巴瘤(NHL)患者与43750例性别年龄匹配对照者的精神药物使用累积风险。NHL患者2年精神药物使用累积风险为16.4%,高于对照者的5.1%(p<.01);侵袭性亚型发病率最高。NHL患者2年自杀/故意自伤风险为0.3%,略高于对照者的0.2%(p=.01)。作者认为应将抑郁和焦虑症状常规评估纳入NHL患者标准随访。

要点

  • NHL患者2年精神药物使用累积风险16.4%,高于匹配对照者的5.1%(p<.01)。
  • 侵袭性NHL亚型精神药物处方发生率最高,诊断后最初几年处方率较高。
  • 侵袭性NHL幸存5年后处方率接近匹配人群,惰性亚型患者风险持续较高。

核心结论

  • NHL患者心理健康并发症常见,精神药物使用和自杀/故意自伤风险均高于匹配对照人群。
  • 作者建议将抑郁和焦虑症状的常规评估纳入NHL患者的标准随访。

研究设计与样本

  • 前瞻性匹配队列研究,利用丹麦全国人口登记数据。
  • 纳入8750例NHL患者和43750例按性别和年龄匹配的对照者,中位年龄68岁,男女比1.6。
  • 中位随访7.1年,分析精神药物(抗抑郁药、抗精神病药和抗焦虑药)的累积使用风险。
  • 同时探索精神科就诊模式以及新发故意自伤或完成自杀情况。

主要发现

  • NHL患者2年精神药物使用累积风险为16.4%,高于匹配对照者的5.1%(p<.01)。
  • 侵袭性NHL亚型患者的精神药物发生率最高。
  • 诊断后最初几年处方率较高,侵袭性NHL幸存5年后处方率接近匹配人群,而惰性亚型患者风险持续较高。
  • NHL患者2年自杀/故意自伤风险为0.3%,高于匹配对照者的0.2%(p=.01)。

临床怎么用

  • 作者建议将抑郁和焦虑症状的常规评估作为NHL患者标准随访的一部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psychological distress following cancer diagnosis may lead to mental health complications including depression and anxiety. Non-Hodgkin lymphomas (NHLs) include indolent and aggressive subtypes for which treatment and prognosis differ widely. Incident use of psychotropic drugs (PDs-antidepressants, antipsychotics, and anxiolytics) and its correlation to lymphoma types can give insights into the psychological distress these patients endure. In this prospective matched cohort study, we used nationwide population-based registries to investigate the cumulative risk of PD use in NHL patients compared to a sex- and age-matched cohort from the Danish background population. In addition, contact patterns to psychiatric departments and incident intentional self-harm or completed suicide were explored. In total, 8750 NHL patients and 43 750 matched comparators were included (median age 68; male:female ratio 1.6). Median follow-up was 7.1 years. Two-year cumulative risk of PD use was higher in NHL patients (16.4%) as compared to the matched comparators (5.1%, p < .01); patients with aggressive NHL subtypes had the highest incidence. Prescription rates were higher in the first years after diagnosis but approached the rate of the matched population 5 years into survivorship in aggressive NHLs, whereas patients with indolent subtypes continued to be at higher risk. NHL patients had a slightly higher two-year risk of suicide/intentional self-harm (0.3%) as compared to the matched comparators (0.2%, p = .01). These results demonstrate that mental health complications among NHL patients are frequent. Routine assessment for symptoms of depression and anxiety should be consider as part of standard follow-up of NHL patients.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Øvlisen AK, Jakobsen LH, Kragholm KH, et al. Mental health among patients with non-Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators. Am J Hematol. 2022. PMID: 35298039. doi:10.1002/ajh.26538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。